Introduction
Type 2 diabetes (T2D) is associated with cognitive decline and an increased risk for dementia in many studies (1) , and cognitive decline and diabetes share several risk and protective factors. Recent meta-analyses show that adherence to the Mediterranean Diet (2) and physical activity (3) are associated with lower risk, and midlife obesity with an increased risk of dementia and cognitive decline (4) . So far the evidence of the importance of lifestyles in cognitive decline comes mainly from observational studies. One lifestyle trial with cognition as a secondary outcome suggests better cognitive functions with the Mediterranean diet (5), but there are very few studies investigating long-term lifestyle changes and cognitive function in a controlled study design.
The Finnish Diabetes Prevention Study (DPS) showed that T2D risk can be decreased by 58% with a lifestyle intervention (6) . Better results were achieved with increasing number of lifestyle goals achieved. Due to shared risk factors we hypothesized that these lifestyle changes could be protective against cognitive decline, and completed ancillary cognitive assessment for the DPS participants on average 13 years after the study baseline. Intention to treat analyses showed no difference between the lifestyle intervention group and the control group in cognitive performance (7) . However, the association between particular lifestyles and cognitive performance were not examined. The aim of this secondary analysis is to investigate how lifestyle factors and changes in them from midlife to older age are associated with later cognitive performance. Specifically, we studied cognitive function in relation with dietary fat and fiber intake, weight, waist circumference and physical activity, the original targets of DPS lifestyle intervention, measured over a 13-year period.
Methods

Subjects and setting
This study was a sub-study to the DPS which has been described in detail previously (8) . In brief, the DPS was a randomized, controlled, multi-center lifestyle intervention study aiming at type 2 diabetes prevention in a high-risk population (ClinicalsTrials.govNCT00518167). Participants were middle-aged (mean 55 years at randomization, range 40 to 65 years), overweight or obese (BMI > 25 kg/m2), and had impaired glucose tolerance (IGT) at baseline. The intervention group (n=265) received frequent individualized dietary, physical activity, and weight reduction counseling by the study nutritionist at 7 face-to-face counselling sessions during the first intervention year and every 3 months thereafter until the end of the intervention phase or diagnosis of diabetes. Voluntary free-of-charge supervised exercise sessions at the gym were also offered to the intervention group participants. The control group (n=257) received only general health advice at baseline. The intervention phase was originally planned to continue for 6 years for each participant, but was prematurely discontinued based on the interim analyses showing a strong benefit in the lifestyle intervention group. Consequently, the average duration of the intervention phase was 4 years (range 1-6 years). The active intervention was followed by post-intervention follow-up phase with annual examinations. Cognition sub-study was initiated in 2009, on average 9 years after the end of the intervention phase (13 year after the randomization). The DPS study protocol was originally approved by the ethics committee of the National Public Health Institute in Helsinki, and the North Ostrobothnia Hospital District approved the follow-up study and the cognition study. All participants gave written informed consent at baseline, at the beginning of the follow-up, and prior to the cognitive assessments.
Clinical Measurements
Baseline and annual examinations comprised 2-hour oral glucose tolerance test (OGTT), a medical history, and a physical examination with measurements of height (without shoes), weight (in light indoor clothes), waist circumference (midway between the lowest rib and iliac crest to the nearest 1 mm) and systolic and diastolic blood pressure (two measurements with a standard sphygmomanometer in sitting position, using the right arm, after 10 minutes of rest). BMI was calculated dividing body weight (kg) with the squared height (m2); for each person, the height measured at baseline was used for all time points. Average BMI (kg/m 2 ) and waist circumference (cm) based on all available measurements during the study period were calculated. The Apolipoprotein E (APOE) genotypes were analysed using the polymerase chain reaction (PCR) with slight modifications, as described elsewhere (9) .
Lifestyle assessment
A 3-day food record was completed and analysed at baseline, three times during the active intervention phase (years 1, 2 and 3), and twice during the follow-up. Recording was facilitated with a picture booklet, and completed records were checked by the study nutritionist. Nutrient intakes were calculated using a dietary analysis program and database developed in the Finnish National Public Health Institute (10) . Average daily intakes of energy from total fat (E%), energy from saturated fat (SFA; E%) and dietary fiber (g) were calculated at baseline (intakes representing the time before the DPS) and averaged over the combined intervention and follow-up phase (intakes representing the time during the DPS). Changes in nutrient intakes were calculated by subtracting the baseline value from the averaged value.
Physical activity was self-reported. Participants reported their usual weekly frequency of physical activity with a fourcategory question, which was used to determine achievement of the exercise goal. They additionally filled in the validated Kuopio Ischemic Heart Disease (KIHD) risk factor study questionnaire (11) to assess annual leisure-time physical activity (LTPA) in more detail. Mean weekly amount of moderate-to-vigorous LTPA (hours) was calculated annually and averaged over the whole study period.
Lifestyle goals
The five main goals of the DPS lifestyle intervention were weight reduction of 5% or more; less than 30% of the energy from fat; less than 10% of the energy from SFA; fiber intake of 15g/1000 kcal (3.6 MJ) or more; and moderate intensity physical activity 30 min/day or more in average. Achievement of the dietary goals was determined based on mean intake during the intervention phase. Percentual weight change from baseline was defined at year 3, as well as physical activity response, using the last observation carried forward to replace missing values.
Cognitive assessment
The cognitive assessment was conducted twice: in 2009, on average 13 years after the DPS baseline, and again in 2011. All eligible participants in both former intervention and control groups (excluding those who had withdrawn from the study or died) were mailed an invitation letter to participate. Cognitive function was assessed by trained study nurses using the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (12) neuropsychological test battery (standardized Finnish translation) which is a sensitive measure for cognitive changes observed in Alzheimer's disease, and Trail Making Test A (TMT) (letters) that measures visuomotor speed/ executive function (13) . All participants with at least one cognitive assessment (n=364 for CERAD, n=362 for TMT) were included using the first available observation for each.
The Finnish CERAD Battery is composed of 1) Verbal fluency (animals) 2) Modified Boston Naming test (15 words) 3) Mini-Mental State Exam 4) Word List Memory (ten words, three trials) 5) Constructional praxis 6) Word List Recall (delayed recall of the ten words) 7) Word List Recognition (recognition of the ten words out of 20 words) 8) Constructional praxis recall 9) Clock drawing. We calculated the CERAD total score (CERAD-TS) to measure overall cognitive performance according to Chandler et al (14) . The TMT was calculated as time in seconds without upper limit (longer time indicating worse performance).
Weight and waist change profiles
For BMI and waist circumference, separate mean values were calculated for the active intervention phase and for the follow-up phase. Weight change categories were determined first as weight loss vs. weight gain during the intervention phase; then as loss vs. gain from intervention to followup phase. Similar categorization was applied for waist circumference. Finally, change profiles for BMI and waist were defined as follows: 1) decrease (during intervention) + decrease (during follow-up); 2) decrease + increase; 3) increase + decrease; 4) increase + increase, respectively.
Statistical Methods
Baseline characteristics were compared using t-test or chi 2 -test as applicable. Linear regression modeling was applied in all cognition analyses. We first adjusted for age and education (Model A), with education being both a surrogate for socioeconomic status and for cognitive reserve. In the second model (Model B) additional adjustments were made for sex, APOE ε4 carrier status, baseline smoking, baseline systolic blood pressure, and intervention allocation. Missing baseline systolic blood pressure values (n=2), education (n=1) and smoking (n=1) were replaced with values measured at year 1. APOE ε4 carrier status was coded as 1 for any APOE ε4 and 0 for none. For missing APOE information (n=10) replacement with value 0.5 was applied and variable was entered as continuous.
Cognitive scores were skewed to the right, and box-cox transformation (15) improved normality. Hence all regression analyses were conducted with transformed cognition scores. For the amount of physical activity, distribution was skewed to the left and square-root transformation was applied. The transformations did not change results markedly, and we present the regression estimates using non-transformed models to facilitate interpretation. All p-values presented are based on models using box-cox transformation (and square-roottransformation, where applicable). One influential outlier in the CERAD-TS, scoring 38 points, was removed from the final analysis, although keeping the outlier in the model would not have changed the presented results.
First, the compliance to the original DPS lifestyle intervention goals was analysed for the intervention phase and a success score indicating the total amount of goals was calculated. Second, linear models were run to investigate the linear association between cognitive performance and general level of the same lifestyle factors and changes in them, using data from all available years. Furthermore, weight change profiles were analysed as factor variables.
We have previously reported that there were no differences in cognition between the former intervention and control groups in cognitive performance (7), and therefore all analyses in this paper were performed for the whole group combined, adjusting for the intervention allocation.
Analyses were conducted with STATA for Windows, release 11.2 (StataCorp LP, TX). p-value <0.05 was considered statistically significant.
Results
Characteristics
The cognition study included 364 participants (70% of the original DPS cohort). The participants had lower systolic blood pressure at baseline and during the study period, but there were no other differences compared with the non-participants ( Table 1 ). The mean age was 55.1±6.8 years at baseline and 68.3±6.8 years at cognition assessment. The cognition was assessed on average 13 years after the baseline visit (range 11 to 18 years, due to lengthy recruitment period) and the average time between the last lifestyle measurement and the cognition assessment was 4 years for dietary variables and 2 years for weight and physical activity variables. The median number of measurements was for dietary intake 5 (range 1 to 5); for physical activity 9 (range 1 to 12); and for BMI and waist circumference 10 (range 2 to 12). Lifestyle factors at baseline or during the study did not differ between participants and nonparticipants of the cognition study (results not shown). 
Achievement of lifestyle goals
After three years of the intervention, 86% of the cognition study participants achieved at least one lifestyle goal, but only 3% achieved all five goals (n=9). Achievement of each of the goals was more common among the intervention group (Chi 2 -test, p<0.05 for all). Achievement of the fat goal during the intervention phase was associated with better performance in the CERAD-TS, but other goals showed non-significant associations (Table 2 ). Higher number of goals achieved i.e. the high success score predicted better CERAD-TS (p for trend 0.012). No association with the TMT was detected.
Lifestyle factors at baseline and lifestyle change during the study
Neither diet nor physical activity at baseline was related to the cognitive performance (Table 3) .
Lower intake of total fat and SFA during the whole study period, as well as greater reduction in either one predicted better performance in CERAD-TS. Lower BMI or waist circumference at baseline and during the study was associated with better CERAD-TS. In addition, greater amount of moderate-to-vigorous physical activity during the study was associated with better CERAD-TS. These results remained virtually unchanged when excluding those with less than 3 lifestyle measurements (n=2-37 depending on the variable), or those with no data from the follow-up phase (n=7-77). However, the association between physical activity and CERAD-TS became non-significant by both exclusions (results not shown).
Weight change profiles
We found no differences in cognition between participants with weight loss vs. those with weight gain during the intervention phase, whereas weight loss between the intervention and follow-up phases predicted poorer performance in CERAD-TS (p=0.008 with full adjustment). Weight loss during the intervention followed by weight gain thereafter (profile "D-I") predicted significantly better CERAD-TS compared with any other weight profile ( Figure  1 ). Other groups did not differ from each other. The group with decreased waist circumference from baseline to the intervention phase had better performance in CERAD-TS than those with increased waistline (p=0.007, fully adjusted model), whereas those with decrease from the intervention to the follow-up phase performed worse (p=0.004). The waist change profile with decrease during the intervention and increase thereafter (profile "D-I") was significantly advantageous in CERAD-TS (Figure 2 ). The TMT results were non-associated with weight or waist changes (data not shown). 
Discussion
Our results show that a long-term healthier lifestyle and positive lifestyle changes are associated with better cognition later in life among a population with IGT at baseline. Obesity measures appeared to have a two-sided relationship as lower BMI and waist circumference at baseline and during the intervention phase were associated with better cognitive function, whereas declining weight prior to cognitive assessment predicted poorer cognition, possibly due to reverse causality.
Dietary intervention studies focusing on cognitive Data are presented as adjusted mean (95% CI), adjusted for age and education. Better performance is indicated by higher CERAD-TS and shorter time in TMT; a. Model A with box-cox transformed cognition scores, adjusted for age and education; b. Model B with box-cox transformed cognition scores, adjusted additionally for sex, APOE ε4 carriers status, and smoking status, systolic blood pressure, and intervention allocation.
ASSOCIATION OF LONG-TERM DIETARY FAT INTAKE, EXERCISE, AND WEIGHT WITH LATER COGNITIVE FUNCTION
outcomes are scarce. The DASH-diet, originally developed to decrease hypertension, improved cognitive function (16) over 4 months, but so far no long-term dietary intervention studies investigating cognitive changes are available. One cardiovascular disease prevention trial suggested that Mediterranean diet was beneficial for cognition after 6 years of intervention (5), but unfortunately this study lacks the baseline cognition assessment as does our study. In the DPS, cognitive performance did not differ between the intervention and control groups despite the difference in diabetes incidence. Lifestyle changes reported in this paper may partially explain the lack of differences; both groups actually improved their lifestyle during the study, and this may have diluted the differences between the groups. The control group actually also received health advice and monitoring, although with less intensity than the intervention group. Our results showing that both total fat and SFA are associated with worse cognitive function are in line with previous epidemiological studies concerning SFA (17) (18) (19) , although not all studies confirm this association (20) . Total fat intake has been associated with increased risk for AD (21, 22) , and total fat intake from milk and spreads with poorer cognitive function (17) . Other fatty acids such as higher intake of monounsaturated fatty acids (19) or lower ratio of polyunsaturated fatty acids to SFA (18) have also been associated with better cognitive function in these studies. To Table 3 Mean level of the lifestyle factors during the study and their mean change in association with later cognitive performance Cognition data are presented as unstandardized regression coefficient (95% CI) representing change in cognitive scores per one unit increase in lifestyle factors. Regression coefficients from model using non-transformed cognitions score and p values from models using box-cox transformed cognition scores. Better performance is indicated by higher CERAD-TS and shorter time in TMT. Model adjusted for age, education, sex, APOE ε4 carrier status and smoking status, systolic blood pressure, and BMI at baseline.
our knowledge, this is the first study linking reduction in total fat/SFA intake to better cognitive function. We only focused on fats that were emphasized in the original DPS intervention, which is one of the limitations in our study. Some studies also suggest a positive association between fiber intake and cognitive function (23, 24) , although we found no evidence of such relationship. Fiber intake in Finland is relatively high, and was additionally emphasized in the lifestyle intervention, which may result in less variability between the participants. Physical activity has been linked to less cognitive decline and lower risk of AD (25) , and lower risk of mild cognitive impairment (26) , but associations were weaker among diabetic participants (27) . The association we found was relatively weak and diminished after excluding those with only few measurements. There are only few studies investigating changes in physical activity in relation to cognition or dementia. One study focusing on physical activity (28) and other on leisure and social activities (29) both showed that remaining active over long time or becoming active was linked to lower risk of dementia later on. Short-term clinical trials (6 months) have shown some benefits among those with mild cognitive impairment (30, 31) and also among participants with glucose intolerance (32) .
Our findings about associations between higher BMI or waist circumference and worse cognitive performance are in agreement with previous prospective studies (33, 34) , but findings regarding weight loss are more controversial. Stable weight has been suggested the most beneficial (35) , and weight loss 5 years prior to the cognitive assessment has predicted poorer results (36) , in accordance with our study. However, we also found decline in waistline to predict poorer cognition, whereas other studies found no evidence for a relationship between waist change and cognitive function (35, 36) .
Interestingly, among our overweight participants, a combination of weight loss during the intervention phase but no weight loss thereafter appeared the most beneficial. Weight loss during the intervention was presumably intentional, whereas the weight change thereafter may be confounded by unintentional weight loss, which can be a sign of pre-clinical AD (37) . A small pilot study indicated that intentional weight loss would be beneficial for cognitive function (38) , but another trial aiming to weight loss among diabetes patients had no effect on cognition assessed cross-sectionally later in life (39) . Weight loss close to cognitive assessment could be a marker, rather than a cause, of underlying cognitive or other health problems. Furthermore, our participants were older during the follow-up and the associations between traditional risk factors and cognitive functions may change with age due to reverse causality. Several studies have demonstrated a decline in weight, blood pressure or cholesterol prior to diagnosis of dementia (40) , and for example presence of the metabolic syndrome has actually been linked to less cognitive decline in old age (41) .
Among the strengths of our study are the repeated lifestyle measurements that were carried out frequently and using relatively precise methods such as food diaries and detailed KIHD questionnaire during a long period of time. We were also able to assess changes in lifestyle over a long time which is not usually possible. Most of the previous studies use only one single dietary assessment. Averaging several measurements gives a more reliable estimate for dietary intake over a long time. For obesity measures we had even more frequent time series and thus were able to see different patterns in weight changes.
There are also limitations that need to be addressed. Most importantly, the cognitive measurement was conducted only at the end of the study and no data on baseline cognition were collected. Therefore it is possible that those who achieved and maintained healthier lifestyle during the study may have had better cognition to start with. However, we had a relatively young group of participants, with a relatively high level of cognitive function even at the end of our follow-up study. Due to the long follow-up there were also drop-outs, and only 70% of the original cohort participated in the cognition study. Those with cognitive or other health problems may have been unable to participate, even though the baseline characteristics of the cognition cohort did not differ markedly from the entire cohort. Our analyses were focused on the lifestyles that were subject to the original intervention of the DPS, whereas other lifestyle factors could also have affected cognitive function along with the studied factors. Furthermore, we were not able to distinguish intentional and unintentional weight reduction, which, like said before, could have opposite effects on cognition. Lack of statistical power may also have an impact on the analyses between cognition and separate goals, as not so many participants achieved the lifestyle goals. Furthermore, all our participants had an increased risk of diabetes at baseline, and almost half of them developed diabetes during the study, and therefore the results of our study are best generalizable to persons with IGT.
Lifestyle interventions have become standard of care for persons with IGT, and our results highlight the potential importance of lifestyle factors in maintaining good cognitive functions in this population also in older age. Furthermore, the DPS intervention goals indicate the benefits with a multigoal-approach: cognitive performance improved with the total amount of goals achieved. Multidomain interventions have been suggested to be best intervention strategy also to support healthy aging (42) . However, due the previously reported lack of difference between the intervention and control groups it remains unclear whether a lifestyle intervention in mid-life is efficient enough to alter cognitive functions later in life as it has been shown to do with prevention of diabetes (43) . The effect of intentional and unintentional weight loss, and also the effect of changes in diet and exercise in different time points in life on cognition deserves more investigation in future studies. Lifestyle intervention trials with cognitive functions as primary outcomes, cognition biomarkers, and long follow-up are necessary to confirm the potential benefits of lifestyle interventions on cognition.
